Russel Hayward

Form D signer

Russel Hayward

Chief Executive Officer at EtiraRX

Form D signer

Capital raised by EtiraRX

$2.3M+$2.3M latest round

1 Form D filing · first filed Apr 2026 · Dallas, TX

CURRENT ROLE: Chief Executive Officer
SECTOR: Biotech
COMPANY FILINGS: 1
TEAM ON FILE: 2
FOUNDED: —
30D INTEREST: 1 ↗

Career

1 company on file

EtiraRXBiotech · Dallas, TXsince Apr 2026

Chief Executive Officer

Signatory on EtiraRX's Form D filings · $2.3M raised across 1

Company filings

via EDGAR · Form D for EtiraRX1

DateCompanyFormAmountRole on filing

Apr 17, 2026EtiraRXForm D+$2.3MChief Executive Officer

Form DApr 17, 2026 · EtiraRX+$2.3Mas Chief Executive Officer

Overview

Last filing Apr 17, 2026

Russel Hayward is on file as Chief Executive Officer at EtiraRX in Dallas, TX. EtiraRX has 1 Form D filing on record, $2.3M raised in total. Russel Hayward appears as a signatory on the company's filings.

LinkedIn profile

Teammates

EtiraRX · 1

Annalisa JenkinsDirector

Products

EtiraRX · 1

ERX-315Clinical-stage oncology therapeutic

An investigational oral small-molecule cancer therapeutic in Phase 1, enrolling adult patients with advanced, unresectable and/or metastatic solid tumors including breast, ovarian, pancreatic and endometrial cancer and hepatocellular carcinoma, for whom standard therapies are ineffective or unavailable.